Trial intelligence / Profile preview

Propofol vs Sevoflurane in Cancer Surgery Prognosis

NCT05926336Phase 4Recruiting

Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Start
May 2023
Primary completion
Jul 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of propofol injection (veterinary) in lung cancer, brain tumor, liver cancer, ovarian cancer, sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Started May 2023; status: recruiting.

02

Drugs

propofol injection (veterinary)
03

Conditions

lung cancerbrain tumorliver cancerovarian cancer

Beyond the preview

Go deeper on NCT05926336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05926336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call